Failure of ascorbic acid to inhibit fanft induced bladder cancer

M. S. Soloway, S. M. Cohen, J. B. Dekernion, L. Persky

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


L ascorbic acid has been shown to reduce the elevated level of urinary chemiluminescence found in patients with bladder cancer. Thus, it has been suggested that vitamin C might be efficacious in bladder tumor prophylaxis. However, there is no clinical evidence to support this thesis. The authors evaluated whether L ascorbic acid given concomitantly with the urinary carcinogen N [4 (5 nitro 2 furyl) 2 thiazolyl]formamide (FANFT) was capable of reducing the incidence of subsequent bladder tumors. No inhibitory effect was observed. Unless evidence is obtained demonstrating bladder tumor prevention by L ascorbic acid its routine administration to patients with bladder cancer is not indicated.

Original languageEnglish (US)
Pages (from-to)483-486
Number of pages4
JournalJournal of Urology
Issue number4
StatePublished - 1975
Externally publishedYes

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Failure of ascorbic acid to inhibit fanft induced bladder cancer'. Together they form a unique fingerprint.

Cite this